+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antiemetics Drugs Market Size, Share & Trends Analysis Report by Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 150 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5921045
Description Jump to:
The global antiemetics drugs market size is expected to reach USD 11.20 billion by 2030, exhibiting a CAGR of 5.98% from 2024 to 2030. Factors such as the increasing strategic initiatives of the key players coupled with the increasing prevalence of various diseases causing nausea and vomiting are propelling market demand forward.

The rising activity of major industry players is one of the major factors bolstering the demand for antiemetics drugs. Industry participants are undertaking various initiatives such as partnerships, acquisitions, new product launches, product approvals, and expansions to strengthen their position in the antiemetics drugs market. For instance, in May 2020, the U.S. Food and Drug Administration approved an AKYNZEO injection from the Helsinn Group for the prevention of nausea and vomiting induced by chemotherapy. Thus, increasing novel product approvals are anticipated to drive industry growth in the coming years.

In addition to key indications such as chemotherapy and postoperative nausea and vomiting (PONV), other conditions such as food poisoning and alcohol consumption are also driving the demand for these medicines over the forecast period. An article published by NCBI in November 2021 suggests that certain over-the-counter antiemetics, such as Bismuth Subsalicylate, are effective in addressing nausea and vomiting associated with food poisoning.

Moreover, a study published in Frontiers in October 2022 reported that ondansetron, a serotonin receptor antagonist, is an effective treatment for alcohol use disorder in patients with early onset alcoholism (EOA). Consequently, the demand for antiemetic medicines is expected to rise in response to increased alcohol consumption and incidents of food poisoning.

Antiemetics Drugs Market Report Highlights

  • On the basis of drug type, the serotonin-receptor antagonists segment dominated the market at 29.71% in 2023 and this dominance can be attributed to the rising cases of cancer coupled with the increasing use of serotonin-receptor antagonist drugs.
  • Based on the application, the chemotherapy segment was the largest revenue contributor to the market with a share of 45.70% in 2023 owing to the increasing product launches targeting nausea and vomiting associated with chemotherapy.
  • In the end-use segment, the retail pharmacy segment dominated the market with a revenue share of 47.91% in 2023. In contrast, the other segment is anticipated to register the fastest growth over the forecast period.
  • The North America region dominated the market with a share of 36.52% in 2023 owing to the presence of major players like Pfizer, Merck Co & Inc, and GSK plc. On the other hand, Asia-Pacific is expected to showcase the fastest growth over the forecast period.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Segment Definitions
1.1.1. Drug Type Segment
1.1.2. Application Segment
1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Research Assumptions
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Target Diseases
3.2.1.2. Rising Investments by Industry Participants in R&D Activities
3.2.2. Market Restraint Analysis
3.2.2.1. Adverse Effects Associated with Anti emetics Drugs
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Drug Type Business Analysis
4.1. Antiemetics Drugs Market: Drug Type Movement Analysis
4.2. Serotonin-Receptor Antagonists
4.2.1. Serotonin-Receptor Antagonists Market, 2018-2030 (USD Million)
4.3. Anticholinergics
4.3.1. Anticholinergics Market, 2018-2030 (USD Million)
4.4. Dopamine Receptor Antagonists
4.4.1. Dopamine Receptor Antagonists Market, 2018-2030 (USD Million)
4.5. Neurokinin Receptor Antagonists
4.5.1. Neurokinin Receptor Antagonists Market, 2018-2030 (USD Million)
4.6. Others
4.6.1. Other Drug Types Market, 2018-2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Antiemetics Drugs Market: Application Movement Analysis
5.2. Chemotherapy
5.2.1. Chemotherapy Market, 2018-2030 (USD Million)
5.3. Gastroenteritis
5.3.1. Gastroenteritis Market, 2018-2030 (USD Million)
5.4. Post-Operative Surgery
5.4.1. Post Operative Surgery Market, 2018-2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018-2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Antiemetics Drugs Market: End-use Movement Analysis
6.2. Hospital & Clinics
6.2.1. Hospital & Clinics Market, 2018-2030 (USD Million)
6.3. Retail Pharmacy
6.3.1. Retail Pharmacy Market, 2018-2030 (USD Million)
6.4. Others
6.4.1. Other End-use Market, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Antiemetics Drugs Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Antiemetics Drugs Market, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. U.S. Antiemetics Drugs Market, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Canada Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. UK Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Germany Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. France Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Italy Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Spain Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Denmark Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Sweden Antiemetics Drugs Market, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Norway Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Japan Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. China Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. India Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Australia Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Thailand Antiemetics Drugs Market, 2018-2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. South Korea Antiemetics Drugs Market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Antiemetics Drugs Market, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Brazil Antiemetics Drugs Market, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Mexico Antiemetics Drugs Market, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Argentina Antiemetics Drugs Market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. MEA Antiemetics Drugs Market, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. South Africa Antiemetics Drugs Market, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Saudi Arabia Antiemetics Drugs Market, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. UAE Antiemetics Drugs Market, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Kuwait Antiemetics Drugs Market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Pfizer Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Cipla Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Eagle Pharmaceuticals, Inc.
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Johnson & Johnson Services, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. GSK plc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Astellas Pharma Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. GLENMARK PHARMACEUTICALS LTD.
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Viatris Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Baxter
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 4 Global Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 5 Global Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 6 Global Antiemetics Drugs Market, By Region, 2018-2030 (USD Million)
Table 7 North America Antiemetics Drugs Market, By Country, 2018-2030 (USD Million)
Table 8 North America Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 9 North America Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 10 North America Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 11 U.S. Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 12 U.S. Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 13 U.S. Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 14 Canada Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 15 Canada Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 16 Canada Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 17 Europe Antiemetics Drugs Market, By Country, 2018-2030 (USD Million)
Table 18 Europe Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 19 Europe Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 20 Europe Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 21 UK Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 22 UK Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 23 UK Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 24 Germany Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 25 Germany Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 26 Germany Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 27 France Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 28 France Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 29 France Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 30 Spain Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 31 Spain Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 32 Spain Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 33 Italy Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 34 Italy Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 35 Italy Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 36 Denmark Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 37 Denmark Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 38 Denmark Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 39 Norway Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 40 Norway Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 41 Norway Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 42 Sweden Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 43 Sweden Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 44 Sweden Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 45 Asia-Pacific Antiemetics Drugs Market, By Country, 2018-2030 (USD Million)
Table 46 Asia-Pacific Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 47 Asia-Pacific Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 48 Asia-Pacific Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 49 China Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 50 China Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 51 China Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 52 Japan Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 53 Japan Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 54 Japan Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 55 India Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 56 India Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 57 India Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 58 South Korea Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 59 South Korea Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 60 South Korea Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 61 Australia Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 62 Australia Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 63 Australia Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 64 Thailand Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 65 Thailand Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 66 Thailand Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 67 Latin America Antiemetics Drugs Market, By Country, 2018-2030 (USD Million)
Table 68 Latin America Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 69 Latin America Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 70 Latin America Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 71 Brazil Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 72 Brazil Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 73 Brazil Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 74 Mexico Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 75 Mexico Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 76 Mexico Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 77 Argentina Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million),
Table 78 Argentina Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 79 Argentina Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 80 MEA Antiemetics Drugs Market, By Country, 2018-2030 (USD Million)
Table 81 MEA Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 82 MEA Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 83 MEA Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 84 South Africa Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 85 South Africa Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 86 South Africa Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 87 UAE Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 88 UAE Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 89 UAE Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 90 Saudi Arabia Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million),
Table 91 Saudi Arabia Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 92 Saudi Arabia Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
Table 93 Kuwait Antiemetics Drugs Market, By Drug Type, 2018-2030 (USD Million)
Table 94 Kuwait Antiemetics Drugs Market, By Application, 2018-2030 (USD Million)
Table 95 Kuwait Antiemetics Drugs Market, By End-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Antiemetics drugs market segmentation
Figure 8 Market snapshot, 2023
Figure 9 Market Trends & outlook
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Market restraint relevance analysis (Current & future impact)
Figure 12 PESTEL analysis
Figure 13 Porter’s Five Forces analysis
Figure 14 Global antiemetics drugs market: Drug type outlook and key takeaways
Figure 15 Global antiemetics drugs market: Drug type movement analysis
Figure 16 Global antiemetics drugs market, for serotonin-receptor antagonists, 2018-2030 (USD Million)
Figure 17 Global antiemetics drugs market, for anticholinergics, 2018-2030 (USD Million)
Figure 18 Global antiemetics drugs market, for dopamine receptor antagonists, 2018-2030 (USD Million)
Figure 19 Global antiemetics drugs market, for neurokinin receptor antagonists, 2018-2030 (USD Million)
Figure 20 Global antiemetics drugs market, for other drug types, 2018-2030 (USD Million)
Figure 21 Global antiemetics drugs market: Application outlook and key takeaways
Figure 22 Global antiemetics drugs market: Application movement analysis
Figure 23 Global antiemetics drugs market, for chemotherapy, 2018-2030 (USD Million)
Figure 24 Global antiemetics drugs market, for gastroenteritis, 2018-2030 (USD Million)
Figure 25 Global antiemetics drugs market, for post-operative surgery, 2018-2030 (USD Million)
Figure 26 Global antiemetics drugs market, for others, 2018-2030 (USD Million)
Figure 27 Global antiemetics drugs market: End-use outlook and key takeaways
Figure 28 Global antiemetics drugs market: End-use movement analysis
Figure 29 Global antiemetics drugs market, for hospital & clinics, 2018-2030 (USD Million)
Figure 30 Global antiemetics drugs market, for retail pharmacy, 2018-2030 (USD Million)
Figure 31 Global antiemetics drugs market, for others, 2018-2030 (USD Million)
Figure 32 Regional marketplace: Key takeaways
Figure 33 Regional outlook, 2023 & 2030
Figure 34 Global antiemetics drugs market: Region movement analysis
Figure 35 North America antiemetics drugs market, 2018-2030 (USD Million)
Figure 36 US antiemetics drugs market, 2018-2030 (USD Million)
Figure 37 Canada antiemetics drugs market, 2018-2030 (USD Million)
Figure 38 Europe antiemetics drugs market, 2018-2030 (USD Million)
Figure 39 Germany antiemetics drugs market, 2018-2030 (USD Million)
Figure 40 UK antiemetics drugs market, 2018-2030 (USD Million)
Figure 41 France antiemetics drugs market, 2018-2030 (USD Million)
Figure 42 Italy antiemetics drugs market, 2018-2030 (USD Million)
Figure 43 Spain antiemetics drugs market, 2018-2030 (USD Million)
Figure 44 Denmark antiemetics drugs market, 2018-2030 (USD Million)
Figure 45 Sweden antiemetics drugs market, 2018-2030 (USD Million)
Figure 46 Norway antiemetics drugs market, 2018-2030 (USD Million)
Figure 47 Asia-Pacific antiemetics drugs market, 2018-2030 (USD Million)
Figure 48 Japan antiemetics drugs market, 2018-2030 (USD Million)
Figure 49 China antiemetics drugs market, 2018-2030 (USD Million)
Figure 50 India antiemetics drugs market, 2018-2030 (USD Million)
Figure 51 Australia antiemetics drugs market, 2018-2030 (USD Million)
Figure 52 South Korea antiemetics drugs market, 2018-2030 (USD Million)
Figure 53 Thailand antiemetics drugs market, 2018-2030 (USD Million)
Figure 54 Latin America antiemetics drugs market, 2018-2030 (USD Million)
Figure 55 Brazil antiemetics drugs market, 2018-2030 (USD Million)
Figure 56 Mexico antiemetics drugs market, 2018-2030 (USD Million)
Figure 57 Argentina antiemetics drugs market, 2018-2030 (USD Million)
Figure 58 Middle East and Africa antiemetics drugs market, 2018-2030 (USD Million)
Figure 59 South Africa antiemetics drugs market, 2018-2030 (USD Million)
Figure 60 Saudi Arabia antiemetics drugs market, 2018-2030 (USD Million)
Figure 61 UAE antiemetics drugs market, 2018-2030 (USD Million)
Figure 62 Kuwait antiemetics drugs market, 2018-2030 (USD Million)

Companies Mentioned

  • Pfizer Inc.
  • Cipla Inc.
  • Merck KGaA
  • Eagle Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • GSK plc.
  • Astellas Pharma Inc.
  • GLENMARK PHARMACEUTICALS LTD.
  • Viatris Inc.
  • Baxter

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 7.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.2 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Antiemetic Drugs Market by Type (Acetylcholine, Anticholinergics, Antihistamines), Application (Chemotherapy, Post Operative Surgery, Pregnancy), Sales Channel - Forecast 2024-2030 - Product Image

Global Antiemetic Drugs Market by Type (Acetylcholine, Anticholinergics, Antihistamines), Application (Chemotherapy, Post Operative Surgery, Pregnancy), Sales Channel - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Antiemetic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Antiemetic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Antiemetics and Antinauseants Global Market Report 2024 - Product Image

Antiemetics and Antinauseants Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Antiemetic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antiemetic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 109 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.